Edwards cited broader TAVR treatment populations and ongoing evidence generation as key growth drivers for the new year.

Edwards Lifesciences (Irvine, CA) is in the news after The Heart Hospital Baylor Plano used the company's Sapien 3 heart valve for a transapical approach in a patient. The latest phase of this ...

Edwards Lifesciences announced Thursday that the California company has completed three first-in-human implants of the company’s transcatheter mitral valve replacement system. But it is not the only ...

VIENNA, Austria—More data are confirming that if femoral access isn’t possible for transcatheter aortic valve replacement, then operators should at the very least stay out of the thorax when ...